Longevity Peptides: SS-31, MOTS-c, Epithalon & Humanin Research Overview

Longevity peptide research has expanded dramatically in the past decade, driven by advances in mitochondrial biology, telomere science, and cellular senescence. Four compounds represent the leading edge of this field: SS-31 (Elamipretide), MOTS-c, Epithalon, and Humanin. Each targets a distinct hallmark of aging at the molecular level. This overview examines what current research reveals about their mechanisms and study applications.

SS-31 (Elamipretide) — Mitochondrial Inner Membrane Targeting

SS-31 (CAS 736992-21-5) is a tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. The "SS" designation refers to Szeto-Schiller, the researchers who developed the compound. Its key feature is an alternating aromatic-cationic structure that enables selective concentration at the inner mitochondrial membrane (IMM), approximately 1,000-fold higher than in the cytoplasm.

At the IMM, SS-31 interacts directly with cardiolipin — a phospholipid essential for the structural integrity of electron transport chain (ETC) complexes. Age-related cardiolipin peroxidation disrupts ETC function and promotes cytochrome c release, triggering apoptosis. SS-31 protects cardiolipin from peroxidation, restoring ETC efficiency, reducing reactive oxygen species (ROS) production, and preserving the mitochondrial membrane potential necessary for ATP synthesis.

Research areas: ischaemia-reperfusion injury, heart failure, kidney disease, age-related vision loss (retinal mitochondrial dysfunction), and neurodegenerative models.

MOTS-c — Mitochondria-Encoded Metabolic Regulator

MOTS-c is a 16-amino acid peptide encoded by the mitochondrial genome (12S rRNA) rather than nuclear DNA — the only peptide known to be both mitochondrially encoded and released into systemic circulation. It was identified by researchers at the University of Southern California in 2015.

MOTS-c activates AMPK (AMP-activated protein kinase) — the master regulator of cellular energy homeostasis. Under metabolic stress, MOTS-c translocates to the nucleus where it regulates nuclear gene expression, particularly genes involved in folate cycle metabolism, one-carbon metabolism, and antioxidant response. In aged mice, circulating MOTS-c levels decline; exogenous MOTS-c administration in aging models improves insulin sensitivity, reduces obesity-related inflammation, and extends exercise performance.

Research areas: metabolic syndrome, insulin resistance, muscle aging, obesity, and mitochondrial communication signalling.

Epithalon — Telomerase Activation and Pineal Regulation

Epithalon (Epitalon, CAS 307297-39-8) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, an endogenous peptide produced by the pineal gland. It was developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, with research publications spanning four decades.

The primary research mechanism is telomerase activation. In cell culture studies, Epithalon has been shown to activate telomerase (hTERT) in human fibroblasts and somatic cells, resulting in telomere elongation beyond the Hayflick limit in in vitro models. This effect is significant because telomere shortening is a central hallmark of replicative senescence. Research also documents effects on melatonin secretion normalisation (via pineal gland modulation) and cortisol circadian rhythm regulation.

Research areas: telomere biology, cellular senescence, circadian rhythm research, age-related endocrine changes.

Humanin — Cytoprotective Mitochondrial Micropeptide

Humanin (HN) is an 21-amino acid micropeptide encoded by the 16S rRNA region of mitochondrial DNA. Like MOTS-c, it represents the emerging class of mitochondria-derived peptides (MDPs). Humanin was first identified in 2001 by researchers studying Alzheimer's disease — it was found in cDNA from the occipital cortex of Alzheimer's patients and demonstrated neuroprotection in cell models.

Humanin acts through two receptor systems: the formyl peptide receptor-like 1 (FPRL1) and a tripartite receptor complex involving CNTFR, WSX-1, and gp130. Its primary cellular actions are anti-apoptotic: it suppresses Bax-mediated and tBid-mediated apoptotic cascades, protecting cells from stress-induced death. Circulating humanin levels decline with age in humans and in multiple animal models, with particularly steep declines correlated with cognitive decline in longitudinal studies.

Research areas: neuroprotection, Alzheimer's disease models, ischaemia, diabetes-related apoptosis, and reproductive aging.

Comparative Overview